| Primary |
| Depression |
50.0% |
| Bipolar Disorder |
25.0% |
| Drug Use For Unknown Indication |
25.0% |
|
| Drug Level Increased |
25.0% |
| Ecchymosis |
25.0% |
| Oedema Peripheral |
25.0% |
| Syncope |
25.0% |
|
| Secondary |
| Product Used For Unknown Indication |
11.5% |
| Schizophrenia |
11.5% |
| Bipolar Disorder |
10.4% |
| Depression |
9.4% |
| Intentional Overdose |
8.3% |
| Dissociative Identity Disorder |
7.3% |
| Smoking Cessation Therapy |
7.3% |
| Personality Disorder |
6.8% |
| Affective Disorder |
4.7% |
| Depressed Mood |
4.2% |
| Mood Altered |
3.6% |
| Colitis Ulcerative |
3.1% |
| Suicide Attempt |
2.6% |
| Psychotic Disorder |
2.1% |
| Agitation |
1.6% |
| Cluster Headache |
1.6% |
| Schizoaffective Disorder |
1.6% |
| Drug Use For Unknown Indication |
1.0% |
| Hypertension |
1.0% |
| Antidepressant Therapy |
0.5% |
|
| White Blood Cell Count Increased |
18.2% |
| Intentional Overdose |
11.4% |
| Multiple Drug Overdose Intentional |
11.4% |
| Pierre Robin Syndrome |
11.4% |
| Suicide Attempt |
6.8% |
| Toxicity To Various Agents |
6.8% |
| Withdrawal Syndrome |
6.8% |
| Vomiting Projectile |
4.5% |
| Extrapyramidal Disorder |
2.3% |
| Haemoglobin Increased |
2.3% |
| Hyperprolactinaemia |
2.3% |
| Malaise |
2.3% |
| Memory Impairment |
2.3% |
| Psychotic Disorder |
2.3% |
| Pulmonary Thrombosis |
2.3% |
| Serotonin Syndrome |
2.3% |
| Sinus Arrhythmia |
2.3% |
| Suicidal Ideation |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
23.4% |
| Bipolar Disorder |
21.3% |
| Depression |
11.3% |
| Schizophrenia |
10.9% |
| Drug Use For Unknown Indication |
8.4% |
| Schizoaffective Disorder |
3.4% |
| Psychotic Disorder |
2.8% |
| Affective Disorder |
2.2% |
| Mania |
2.2% |
| Agitation |
1.9% |
| Asthma |
1.9% |
| Insomnia |
1.6% |
| Colorectal Cancer |
1.3% |
| Contraception |
1.3% |
| Mood Altered |
1.3% |
| Smoking Cessation Therapy |
1.3% |
| Atrial Fibrillation |
0.9% |
| Back Pain |
0.9% |
| Cardiac Failure Congestive |
0.9% |
| Depressed Mood |
0.9% |
|
| White Blood Cell Count Increased |
20.8% |
| Glomerular Filtration Rate Decreased |
11.7% |
| Overdose |
6.5% |
| Tremor |
6.5% |
| Weight Decreased |
6.5% |
| Myocarditis |
5.2% |
| Withdrawal Syndrome |
5.2% |
| International Normalised Ratio Increased |
3.9% |
| Rash |
3.9% |
| Vomiting |
3.9% |
| White Blood Cell Count Decreased |
3.9% |
| Depressed Level Of Consciousness |
2.6% |
| Diabetes Mellitus |
2.6% |
| Fear |
2.6% |
| Hyponatraemia |
2.6% |
| Neuroleptic Malignant Syndrome |
2.6% |
| Pancreatitis |
2.6% |
| Somnolence |
2.6% |
| Treatment Noncompliance |
2.6% |
| Abnormal Behaviour |
1.3% |
|
| Interacting |
| Mania |
13.4% |
| Drug Use For Unknown Indication |
11.3% |
| Bipolar Disorder |
10.3% |
| Cough |
9.3% |
| Mycoplasma Infection |
9.3% |
| Agitation |
7.2% |
| Hypertension |
7.2% |
| Mood Altered |
7.2% |
| Affective Disorder |
6.2% |
| Product Used For Unknown Indication |
5.2% |
| Headache |
3.1% |
| Acne |
2.1% |
| Acute Sinusitis |
2.1% |
| Blood Cholesterol Increased |
1.0% |
| Depression |
1.0% |
| Insomnia |
1.0% |
| Major Depression |
1.0% |
| Oedema Peripheral |
1.0% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.0% |
|
| Transient Ischaemic Attack |
26.1% |
| Mania |
17.4% |
| Hallucination |
13.0% |
| Drug Level Decreased |
8.7% |
| Memory Impairment |
8.7% |
| Neuroleptic Malignant Syndrome |
8.7% |
| Therapeutic Agent Toxicity |
8.7% |
| Nausea |
4.3% |
| Potentiating Drug Interaction |
4.3% |
|
